| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Bipolar Disorder | |||||
| Mixed Mania | |||||
| Treatment-Resistant Mania | |||||
| 2 | More general conditions related to this trial | ||||
| Affective Disorders, Psychotic | |||||
| Mental Disorders | |||||
| Mood Disorders | |||||
| 3 | Interventions listed in this trial | ||||
| Allopurinol | |||||
| Placebo | |||||
| 4 | More general drug interventions related to this trial | ||||
| Antimetabolites | |||||
| Antioxidants | |||||
| Antirheumatic Agents | |||||
| Enzyme Inhibitors | |||||
| Free Radical Scavengers | |||||
| Gout Suppressants | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Therapeutic Uses | |||||
| 5 | Sponsors listed in this trial | ||||
| Cedars-Sinai Medical Center | |||||
| National Alliance for Research on Schizophrenia and Depression | |||||
|
